Pharmaceutical Industry Payments and Oncologists’ Selection of Targeted Cancer Therapies in Medicare Beneficiaries

This study examines the association between oncologists’ receipt of payments from pharmaceutical manufacturers and drug selection in 2 situations where there are multiple treatment options.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA internal medicine 2018-06, Vol.178 (6), p.854-856
Hauptverfasser:	Mitchell, Aaron P, Winn, Aaron N, Dusetzina, Stacie B
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - economics Conflict of Interest Drug Industry - economics Drug Industry - ethics Humans Letters Medicare - economics Online First Practice Patterns, Physicians' - economics Research Letter United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study examines the association between oncologists’ receipt of payments from pharmaceutical manufacturers and drug selection in 2 situations where there are multiple treatment options.
ISSN:	2168-6106 2168-6114
DOI:	10.1001/jamainternmed.2018.0776